IL2RA - interleukin 2 receptor subunit alpha Gene
Also Known as p55; CD25; IL2R; IMD41; TCGFR; IDDM10
Species: Homo sapiens
About IL2RA
This gene has 7 transcripts (splice variants), 107 orthologues and is associated with 5 phenotypes. Biased expression in lymph node (RPKM 8.0), appendix (RPKM 7.2) and 13 other tissues.
Summary
The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung Cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_000417.3 | NP_000408.1 | interleukin-2 receptor subunit alpha isoform 1 precursor |
| NM_001308242.2 | NP_001295171.1 | interleukin-2 receptor subunit alpha isoform 2 precursor |
| NM_001308243.2 | NP_001295172.1 | interleukin-2 receptor subunit alpha isoform 3 precursor |
| NM_000417.3 | NP_000408.1 | interleukin-2 receptor subunit alpha isoform 1 precursor |
| NM_001308242.2 | NP_001295171.1 | interleukin-2 receptor subunit alpha isoform 2 precursor |
| NM_001308243.2 | NP_001295172.1 | interleukin-2 receptor subunit alpha isoform 3 precursor |
| Molecular Function GO Annotation | Evidence | Références | Source |
|---|---|---|---|
| enables interleukin-2 receptor activity |
IDA
IDA: Inferred from direct assay
|
16293754 | GOA |
| contributes to interleukin-2 receptor activity |
IMP
IMP: Inferred from mutant phenotype
|
2467293 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
16477002 | GOA |
| Biological Process GO Annotation | Evidence | Références | Source |
|---|---|---|---|
| involved in interleukin-2-mediated signaling pathway |
IDA
IDA: Inferred from direct assay
|
16293754 | GOA |
| involved in regulation of T cell tolerance induction |
IMP
IMP: Inferred from mutant phenotype
|
23416241 | GOA |
IL2RA Protein Structure
Sushi: Sushi repeat (SCR repeat) (24 - 79)
Sushi: Sushi repeat (SCR repeat) (125 - 184)
- 0
- 100
- 200
- 272 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
interleukin-2 receptor subunit alpha |
|
Recombinant IL2RA Proteins
| Cat. No. | Nom du produit | Accession | Pureté |
|---|---|---|---|
| HY-P7215 | IL-2R alpha/CD25 Protein, Human (HEK293, N-His) | P01589 (E22-C213) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P7374 | IL-2R alpha/CD25 Protein, Human (HEK293, Fc) | P01589 (E22-C213) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P70628 | IL-2R alpha/CD25 Protein, Human (HEK293, C-His) | P01589 (E22-C213) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78092 | IL-2R alpha/CD25 Protein, Human (Biotinylated, HEK293, His-Avi) | P01589 (E22-C213) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P78412 | IL-2R alpha/CD25 Protein, Human (HEK293, His-Avi) | P01589 (E22-C213) | ≥ 95%, as determined by Bis-Tris PAGE. |
IL2RA Anticorps
| Cat. No. | Nom du produit | Application | Reactivity |
|---|---|---|---|
| HY-P81712 | IL-2 Receptor alpha Antibody (YA1457) | FC, ELISA | Human |
| HY-P82616 | IL-2 Receptor alpha Antibody (YA2361) | IHC-P, ICC/IF | Human |
| HY-P83909 | IL2RA Antibody (YA3606) | WB, IHC-P, ICC/IF, ELISA | Human, Mouse, Monkey, Rat |
| HY-P83909A | IL2RA Antibody (YA3606)(PBS only) | WB, IHC-P, ICC/IF, ELISA | Human, Mouse, Monkey, Rat |
| HY-P84978 | CD25 Antibody (YA4670) | ELISA | Human |
| HY-P85676 | CD25 Antibody (YA5368) | IHC-P, ICC/IF | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Immunodeficiency 41 With Lymphoproliferation And Autoimmunity |
|
|
| Type 1 Diabetes Mellitus 10 |
|
|
| Intermediate Uveitis |
|
|
| Posterior Uveitis |
|
|
| Oligoarticular Juvenile Idiopathic Arthritis |
|
|
| Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis |
|
|
| Covid-19 |
|
|
| Autoimmune Enteropathy |
|
|
| Diphtheria |
|
|
| Vogt-Koyanagi-Harada Disease |
|
|
| Pulmonary Sarcoidosis |
|
|
| Acute Graft Versus Host Disease |
|
|
| Hairy Cell Leukemia |
|
|
| Hypereosinophilic Syndrome |
|
|
| Lymphopenia |
|
|
| Adult T-Cell Leukemia/Lymphoma |
|
|
| Pilonidal Sinus |
|
|
| Mycosis Fungoides |
|
|
| Juvenile Rheumatoid Arthritis |
|
|
| Primary Cutaneous T-Cell Non-Hodgkin Lymphoma |
|
|
| Uveitis |
|
|
| Rheumatoid Arthritis |
|
|
| Localized Scleroderma |
|
|
| Graves' Disease |
|
|
| Tuberculoid Leprosy |
|
|
| Pulmonary Tuberculosis |
|
|
| Diabetes Mellitus |
|
|
| Measles |
|
|
| Mastocytosis |
|
|
| Sarcoidosis 1 |
|
|
| Tetanus |
|
|
| Severe Combined Immunodeficiency, X-Linked |
|
|
| Anaplastic Large Cell Lymphoma |
|
|
| Tropical Spastic Paraparesis |
|
|
| Immune Deficiency Disease |
|
|
| Alopecia Areata |
|
|
| Hemophagocytic Lymphohistiocytosis |
|
|
| Autoimmune Disease |
|
|
| Common Variable Immunodeficiency |
|
|
| Sjogren Syndrome |
|
|
| Panniculitis |
|
|
| Pleural Tuberculosis |
|
|
| Microscopic Polyangiitis |
|
|
| Lymphadenitis |
|
|
| Sezary'S Disease |
|
|
| B-Cell Expansion With Nfkb And T-Cell Anergy |
|
|
| Arthritis |
|
|
| Churg-Strauss Syndrome |
|
|
| Extrinsic Allergic Alveolitis |
|
|
| Acquired Immunodeficiency Syndrome |
|
|
| Multiple Sclerosis |
|
|
| Cervicitis |
|
|
| Systemic Lupus Erythematosus |
|
|
| T-Cell Acute Lymphoblastic Leukemia |
|
|
| Immunodeficiency 63 With Lymphoproliferation And Autoimmunity |
|
|
| Visceral Leishmaniasis |
|
|
| Rubella |
|
|
| Immunodysregulation, Polyendocrinopathy, And Enteropathy, X-Linked |
|
|
| Combined Immunodeficiency |
|
|
| Lymphoma, Hodgkin, Classic |
|
|
| Lymphoma, Non-Hodgkin, Familial |
|
|
| Systemic Mastocytosis |
|
|
| Lymphoma |
|
|
| Hypersplenism |
|
|
| Conjunctivitis |
|
|
| Psoriasis |
|
|
| Myeloid And Lymphoid Neoplasms Associated With Fgfr1 Abnormalities |
|
|
| Severe Combined Immunodeficiency |
|
|
| Human Immunodeficiency Virus Infectious Disease |
|
|
| Fuchs' Heterochromic Uveitis |
|
|
| Hashimoto Thyroiditis |
|
|
| Hematologic Cancer |
|
|
| Peripheral T-Cell Lymphoma |
|
|
| Autoimmune Lymphoproliferative Syndrome |
|
|
| Radiculopathy |
|
|
| Nephrotic Syndrome |
|
|
| Dysgerminoma |
|
|
| Relapsing-Remitting Multiple Sclerosis |
|
|
| Myelofibrosis |
|
|
| Dermatitis, Atopic |
|
|
| Behcet Syndrome |
|
|
| Breast Cancer |
|
|
| Viral Infectious Disease |
|
|
| Disseminated Eosinophilic Collagen Disease |
|
|
| Asthma |
|
|
| Immunodeficiency 31c |
|
|
| Pancytopenia |
|
|
| Lung Cancer |
|
|
| Lymphoproliferative Syndrome 1 |
|
|
| Malaria |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Dyskeratosis Congenita |
|
|
| Inflammatory Bowel Disease |
|
|
| Autoimmune Disease Of Endocrine System |
|
|
| Cerebral Palsy |
|
|
| Renal Cell Carcinoma, Nonpapillary |
|
|
| Colorectal Cancer |
|
|
| Esophageal Tuberculosis |
|
|
| Celiac Disease 1 |
|
|
| Colon Leiomyoma |
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | IL2RA | VGNC | VGNC:56188 |
| Rattus norvegicus | IL2RA | RGD | RGD:2895 |
| Felis catus | IL2RA | VGNC | VGNC:67776 |
| Canis familiaris | IL2RA | VGNC | VGNC:41977 |
| Mus musculus | IL2RA | MGD | MGI:96549 |
| Macaca mulatta | IL2RA | VGNC | VGNC:106063 |
| Others | IL2RA | NCBI |